These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 16128264)
21. Immunisation of 4-6 month old Gambian infants with Edmonston-Zagreb measles vaccine. Whittle HC; Rowland MG; Mann GF; Lamb WH; Lewis RA Lancet; 1984 Oct; 2(8407):834-7. PubMed ID: 6148572 [TBL] [Abstract][Full Text] [Related]
22. Clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine. Fourth report to the medical research council by the measles sub-committee of the committee on development of vaccines and immunisation procedures. Lancet; 1977 Sep; 2(8038):571-5. PubMed ID: 71396 [TBL] [Abstract][Full Text] [Related]
24. Safety and efficacy of transcutaneous vaccination using a patch with the live-attenuated measles vaccine in humans. Etchart N; Hennino A; Friede M; Dahel K; Dupouy M; Goujon-Henry C; Nicolas JF; Kaiserlian D Vaccine; 2007 Sep; 25(39-40):6891-9. PubMed ID: 17764789 [TBL] [Abstract][Full Text] [Related]
25. Measles vaccination: new strategies and formulations. de Vries RD; Stittelaar KJ; Osterhaus AD; de Swart RL Expert Rev Vaccines; 2008 Oct; 7(8):1215-23. PubMed ID: 18844595 [TBL] [Abstract][Full Text] [Related]
26. Live-attenuated measles virus vaccine targets dendritic cells and macrophages in muscle of nonhuman primates. Rennick LJ; de Vries RD; Carsillo TJ; Lemon K; van Amerongen G; Ludlow M; Nguyen DT; Yüksel S; Verburgh RJ; Haddock P; McQuaid S; Duprex WP; de Swart RL J Virol; 2015 Feb; 89(4):2192-200. PubMed ID: 25473055 [TBL] [Abstract][Full Text] [Related]
27. A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus. Brandler S; Ruffié C; Combredet C; Brault JB; Najburg V; Prevost MC; Habel A; Tauber E; Desprès P; Tangy F Vaccine; 2013 Aug; 31(36):3718-25. PubMed ID: 23742993 [TBL] [Abstract][Full Text] [Related]
28. Prospects for the eradication of infectious diseases. Stuart-Harris C Rev Infect Dis; 1984; 6(3):405-11. PubMed ID: 6377445 [TBL] [Abstract][Full Text] [Related]
29. Vaccination against measles: a neverending story. Stittelaar KJ; de Swart RL; Osterhaus AD Expert Rev Vaccines; 2002 Aug; 1(2):151-9. PubMed ID: 12901554 [TBL] [Abstract][Full Text] [Related]
30. Protection against challenge with measles virus (MV) in infant macaques by an MV DNA vaccine administered in the presence of neutralizing antibody. Premenko-Lanier M; Rota PA; Rhodes GH; Bellini WJ; McChesney MB J Infect Dis; 2004 Jun; 189(11):2064-71. PubMed ID: 15143474 [TBL] [Abstract][Full Text] [Related]
32. hCD46 receptor is not required for measles vaccine Schwarz strain replication in vivo: Type-I IFN is the species barrier in mice. Mura M; Ruffié C; Billon-Denis E; Combredet C; Tournier JN; Tangy F Virology; 2018 Nov; 524():151-159. PubMed ID: 30199752 [TBL] [Abstract][Full Text] [Related]
33. The effect of human immunodeficiency virus-1 infection and stunting on measles immunoglobulin-G levels in children vaccinated against measles in Uganda. Waibale P; Bowlin SJ; Mortimer EA; Whalen C Int J Epidemiol; 1999 Apr; 28(2):341-6. PubMed ID: 10342701 [TBL] [Abstract][Full Text] [Related]
34. The recombinant globular head domain of the measles virus hemagglutinin protein as a subunit vaccine against measles. Lobanova LM; Eng NF; Satkunarajah M; Mutwiri GK; Rini JM; Zakhartchouk AN Vaccine; 2012 Apr; 30(20):3061-7. PubMed ID: 22406109 [TBL] [Abstract][Full Text] [Related]
35. Measles vaccines: novel generations and new strategies. Osterhaus AD; de Vries P; van Binnendijk RS J Infect Dis; 1994 Nov; 170 Suppl 1():S42-55. PubMed ID: 7930753 [TBL] [Abstract][Full Text] [Related]
36. Live attenuated measles vaccine expressing HIV-1 Gag virus like particles covered with gp160DeltaV1V2 is strongly immunogenic. Guerbois M; Moris A; Combredet C; Najburg V; Ruffié C; Février M; Cayet N; Brandler S; Schwartz O; Tangy F Virology; 2009 May; 388(1):191-203. PubMed ID: 19345390 [TBL] [Abstract][Full Text] [Related]
37. [Measles immunization and its problems]. Kökkaya A Mikrobiyol Bul; 1982 Jan; 16(1):66-70. PubMed ID: 7144618 [TBL] [Abstract][Full Text] [Related]
38. Experience with live rubella virus vaccine combined with live vaccines against measles and mumps. Smorodintsev AA; Nasibov MN; Jakovleva NV Bull World Health Organ; 1970; 42(2):283-9. PubMed ID: 5310140 [TBL] [Abstract][Full Text] [Related]